J. Finkle

发表

Troponin measurements during drug development--considerations for monitoring and management of potential cardiotoxicity: an educational collaboration among the Cardiac Safety Research Consortium, the Duke Clinical Research Institute, and the US Food and Drug Administration.

L. Newby, C. Dollery, M. Krucoff, 2011, American heart journal.

Electrocardiographic assessment for therapeutic proteins--scientific discussion.

P. Sager, C. Garnett, C. Newton-Cheh, 2010, American heart journal.

Pediatric cardiovascular safety: challenges in drug and device development and clinical application.

N. Stockbridge, M. Krucoff, Jennifer S. Li, 2012, American heart journal.

Multimodality serial follow-up of thoracic aortic aneurysms

Kevin M. Johnson, M. Fischer, J. Elefteriades, 1997 .

Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.

E. Michelson, P. Sager, J. Mason, 2012, American heart journal.

Pharmacologic Management of Atrial Fibrillation

P. Kowey, J. Finkle, K. Plunkitt, 2002 .

The signal averaged ECG in patients with cardiomyopathy

F. Marchlinski, J. Finkle, 1993 .

ICD Data Storage: Value in Arrhythmia Management

F. Marchlinski, D. Schwartzman, D. Callans, 1993, Pacing and clinical electrophysiology : PACE.

Assessing proarrhythmic potential of drugs when optimal studies are infeasible.

Wendy R. Sanhai, P. Kowey, N. Stockbridge, 2009, American heart journal.

Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative.

Jean-Pierre Valentin, Hugo M Vargas, Norman Stockbridge, 2009, American heart journal.

Planning the Safety of Atrial Fibrillation Ablation Registry Initiative (SAFARI) as a Collaborative Pan-Stakeholder Critical Path Registry Model: a Cardiac Safety Research Consortium "Incubator" Think Tank.

D. Mark, H. Calkins, P. Kowey, 2010, American heart journal.

The Cardiac Safety Research Consortium enters its second decade: An invitation to participate.

P. Kowey, G. Gintant, P. Sager, 2016, American Heart Journal.

New precompetitive paradigms: focus on cardiac safety.

Wendy R. Sanhai, N. Stockbridge, M. Krucoff, 2009, American heart journal.

Evaluation of ventricular arrhythmias in early clinical pharmacology trials and potential consequences for later development.

P. Kowey, J. Mason, C. Newton-Cheh, 2010, American heart journal.

What is the risk of sudden cardiac death in patients presenting with hemodynamically stable sustained ventricular tachycardia after myocardial infarction?

R. Gerszten, A. Buxton, J. Finkle, 1996, Journal of the American College of Cardiology.